a public good project by the
Synthesis
Company
of California

© 2026

Yijun Shu | doi.page

0 works0 citations0 h-index

Yijun Shu

Zhejiang Chinese Medical University(CN)Shanghai Jiao Tong University(CN)XinHua Hospital(CN)Tongren Hospital(CN)

Publications by Year

Research Areas

Cholangiocarcinoma and Gallbladder Cancer Studies, RNA modifications and cancer, Cancer-related molecular mechanisms research, Peptidase Inhibition and Analysis, Gallbladder and Bile Duct Disorders

Most-Cited Works

→ Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway(2014)468 cited
→ MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway(2014)232 cited
→ Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study(2014)144 cited
→ A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth(2016)127 cited
→ Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma(2013)117 cited
→ MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway(2017)92 cited

→ Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway(2014)87 cited

→ Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway(2014)81 cited

→ Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer(2015)75 cited

→ Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer(2016)57 cited